Flavia V Castelino Selected Research

Neoplasms (Cancer)

1/2016	Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
11/2012	Lipids and eicosanoids in fibrosis: emerging targets for therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Flavia V Castelino Research Topics

Disease

10	Systemic Scleroderma (Systemic Sclerosis) 09/2022 - 07/2009
6	Fibrosis (Cirrhosis) 12/2016 - 05/2011
4	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021 - 01/2010
3	Disease Progression 01/2023 - 01/2010
3	Connective Tissue Diseases (Connective Tissue Disease) 05/2021 - 01/2010
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016 - 01/2010
2	Immunoglobulin G4-Related Disease 09/2022 - 01/2016
2	Infections 11/2021 - 12/2020
2	Diffuse Scleroderma (Progressive Systemic Sclerosis) 12/2020 - 01/2020
2	Neoplasms (Cancer) 01/2016 - 11/2012
2	Inflammation (Inflammations) 01/2016 - 11/2012
1	general anxiety disorder 09/2022
1	Vasculitis (Vasculitides) 09/2022
1	Calcinosis 10/2020
1	Lung Diseases (Lung Disease) 11/2018
1	Lung Injury 01/2016
1	Rare Diseases (Rare Disease) 11/2013
1	Idiopathic Pulmonary Fibrosis 11/2012

Drug/Important Bio-Agent (IBA)

3	lysophosphatidic acidIBA 12/2016 - 05/2011
3	Bleomycin (Blenoxane)FDA LinkGeneric 12/2016 - 05/2011
2	nintedanibIBA 01/2023 - 05/2021
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 05/2021 - 05/2014
2	Abatacept (Orencia)FDA Link 12/2020 - 01/2020
2	LipidsIBA 12/2016 - 11/2012
2	PAT-048IBA 12/2016 - 01/2016
2	CytokinesIBA 01/2016 - 11/2014
2	Biomarkers (Surrogate Marker)IBA 11/2013 - 01/2010
2	Lysophosphatidic Acid ReceptorsIBA 11/2012 - 05/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2022
1	N 30IBA 09/2022
1	Rituximab (Mabthera)FDA Link 11/2021
1	InterferonsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	CalciumIBA 10/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2016
1	alkylglycerophosphoethanolamine phosphodiesteraseIBA 01/2016
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2016
1	Granzymes (Granzyme)IBA 01/2016
1	SphingolipidsIBA 11/2012
1	EicosanoidsIBA 11/2012
1	LysophospholipidsIBA 11/2012
1	Tyrosine Kinase InhibitorsIBA 07/2009
1	Imatinib Mesylate (Gleevec)FDA Link 07/2009

Therapy/Procedure

7	Therapeutics 11/2021 - 01/2010